Intervention

Metformin 1500 mg daily

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to MetforminNCT00684528 · 2008-06-01

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 DiabetesNCT00383578 · 2006-09-01

Common conditions

Diabetes Mellitus, Type 21 Diabetes Type 21

Leading sponsors

Meir Medical Center1 Novartis Pharmaceuticals1

Trial status mix

COMPLETED1

UNKNOWN1

Phase mix

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.